Campus Life

Creator Of First Synthetic Malaria Vaccine To Visit Texas A&M April 27-28

April 25, 2017

Manuel Elkin Patarroyo. (Vanguardia.com photo)
Manuel Elkin Patarroyo. (Vanguardia.com photo)
By Texas A&M University Marketing and Communications Staff

Manuel Elkin Patarroyo, M.D., Ph.D, a distinguished physician-scientist recognized as the creator of the first synthetic vaccine against malaria, will give two presentations open to all students, faculty and staff April 27-28.

Patarroyo, a professor of molecular pathology at Colombian National University and the Director of the Colombian Institute of Immunology in Bogatá, Colombia, was awarded the TWAS Prize in 1998 for medical sciences. The malaria vaccine SPf66 he developed was a precursor to the vaccine RTS,S, created by scientists at GSK in 1987, which has been given approval by the World Health Organization to take part in a pilot program in Ghana, Kenya and Malawi.

Patarroyo’s presentations are part of the Veterinary Pathobiology Seminar Series at the College of Veterinary Medicine & Biomedical Sciences (CVM).

The campus community is welcome to attend both of Patarroyo’s presentations:

  • The New Vaccines: Rules & Principals for their Development
    Thursday, April 27, 2017 • 6 p.m.
    Interdisciplinary Life Sciences Building (ILSB) (#1530)
    Main Auditorium
    (suggested parking in Cain Garage)
  • The New Vaccines: Developmental Vaccinology
    Friday, April 28, 2017 • 12 p.m.
    Veterinary & Biomedical Education Complex (VBEC)
    VENI Bldg. (#1812), Room 107A

###

Contact:

Robin F. Williams-Callahan
Administrative Coordinator
Department of Veterinary Pathobiology
Tel: 979.862.4923 | Email: RBenbow@cvm.tamu.edu

Related Stories

Recent Stories